Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on L 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel axial chiral bisindole catalysts for asymmetric synthesis. Superior stereoselectivity and mild conditions for pharmaceutical intermediates manufacturing.
Novel palladium-catalyzed carbonylation patent CN115286628B enables efficient synthesis. Offers supply chain reliability and cost reduction for pharmaceutical intermediates manufacturing.
Patent CN102964271B details a novel one-step Pd-catalyzed synthesis of 2-cyano-4'-methylbiphenyl, offering significant cost reduction and scalability for sartan drug manufacturers.
Novel metal-free synthesis of trifluoromethyl 1,2,4-triazines via [3+3] cycloaddition. Offers cost reduction in API manufacturing and scalable production capabilities.
Patent CN116253692A enables efficient, metal-free synthesis of trifluoromethyl triazines under ambient conditions, offering significant cost savings and supply chain reliability for pharmaceutical intermediates.
Patent CN116621792B enables efficient, water-based synthesis of N-butyl-benzisothiazolinone oxide with high yield, offering sustainable cost reduction and scalable supply for pharmaceutical intermediates.
Patent CN113880781B enables scalable, mild synthesis of trifluoromethyl triazoles using glucose, offering supply chain resilience and cost reduction for pharmaceutical intermediates.
Patent CN119306765B enables high-yield asymmetric synthesis of florfenicol and chloramphenicol intermediates with superior stereoselectivity and scalable catalytic efficiency.
Patent CN117164506B enables scalable, high-yield synthesis of indeno[1,2-b]indole-10(5H)-one with simplified purification, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN115260188B enables scalable, cobalt-catalyzed synthesis of tetrahydro-beta-carboline ketones with high substrate tolerance and simplified purification, offering supply chain resilience for pharmaceutical intermediates.
Patent CN113307778A enables mild-condition synthesis of 3-trifluoromethyl triazoles with high efficiency and scalable production for pharmaceutical supply chains.
Patent CN113004293A enables room-temperature gold-catalyzed synthesis of tetrahydrofuran indolines with up to 99% yield, enhancing supply chain reliability for anti-cancer drug intermediates.
This patent reveals a novel one-step palladium-catalyzed carbonylation method for indolo[2,1a]isoquinoline synthesis with enhanced substrate tolerance and simplified manufacturing processes enabling reliable pharmaceutical intermediate supply chains.
Patent CN113880781B enables efficient glucose-based synthesis of trifluoromethyl triazoles with enhanced supply chain reliability and sustainable manufacturing advantages.
Novel palladium-catalyzed method using benzisoxazole as dual source enables high-yield synthesis with simplified supply chain and reduced manufacturing costs.
Patent-CN-7 introduces an efficient one-step palladium-catalyzed method for indolo[2,1a]isoquinoline synthesis offering significant cost reduction and scalable production capabilities.
Patent CN106188044A details an iodine-catalyzed method for synthesizing thiolated imidazo[1,5-a]N-heterocycles without transition metals, enabling mild conditions and broad substrate scope for reliable pharmaceutical intermediate supply.
Patent CN113307790B enables efficient triazole synthesis without heavy metals, enhancing supply chain reliability and reducing manufacturing costs for pharmaceutical intermediates.
Patent CN115636829B introduces a novel rhodium-catalyzed method for synthesizing trifluoromethyl benzo[1,8]naphthyridine compounds with high efficiency and scalability enabling cost reduction in electronic chemical manufacturing and reliable supply for optoelectronic applications
Patent CN115215810B enables heating-promoted synthesis of high-purity triazole intermediates with significant cost reduction and enhanced supply chain reliability in pharmaceutical manufacturing.